Insider Transactions in Q2 2023 at Kala Pharmaceuticals, Inc. (KALA)
Insider Transaction List (Q2 2023)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 22
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
158,873
+36.49%
|
-
|
|
Jun 22
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
4,884
+17.46%
|
-
|
|
Jun 22
2023
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
48,698
+36.51%
|
-
|
|
Jun 22
2023
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
49,356
+36.52%
|
-
|
|
Jun 22
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
36,144
+36.54%
|
-
|
|
Jun 22
2023
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
37,559
+36.73%
|
-
|
|
Jun 22
2023
|
Gregory D Perry |
BUY
Grant, award, or other acquisition
|
Direct |
6,956
+25.74%
|
-
|
|
Jun 22
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
36,847
+37.31%
|
-
|
|
Jun 22
2023
|
Howard B Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
9,088
+24.66%
|
-
|
|
Jun 22
2023
|
Andrew I Koven |
BUY
Grant, award, or other acquisition
|
Direct |
8,915
+25.71%
|
-
|
|
Jun 22
2023
|
C. Daniel Myers |
BUY
Grant, award, or other acquisition
|
Direct |
4,884
+27.76%
|
-
|
|
Jun 22
2023
|
Marjan Farid |
BUY
Grant, award, or other acquisition
|
Direct |
4,792
+27.89%
|
-
|
|
May 31
2023
|
Mark T Iwicki CHIEF EXECUTIVE OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
71,715
+37.87%
|
-
|
|
May 31
2023
|
Todd Bazemore |
BUY
Grant, award, or other acquisition
|
Direct |
21,158
+37.02%
|
-
|
|
May 31
2023
|
Romulus K Brazzell |
BUY
Grant, award, or other acquisition
|
Direct |
17,916
+32.95%
|
-
|
|
May 31
2023
|
Mark S. Blumenkranz |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+19.42%
|
-
|
|
May 31
2023
|
Andrew I Koven |
BUY
Grant, award, or other acquisition
|
Direct |
2,197
+40.28%
|
-
|
|
May 31
2023
|
Mary Reumuth CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
14,736
+35.63%
|
-
|
|
May 31
2023
|
C. Daniel Myers |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+50.0%
|
-
|
|
May 31
2023
|
Eric Trachtenberg |
BUY
Grant, award, or other acquisition
|
Direct |
15,639
+36.56%
|
-
|
|
May 31
2023
|
Gregory D Perry |
BUY
Grant, award, or other acquisition
|
Direct |
1,738
+40.65%
|
-
|
|
May 31
2023
|
Darius Kharabi CHIEF BUSINESS OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
2,648
+9.56%
|
-
|
|
May 31
2023
|
Marjan Farid |
BUY
Grant, award, or other acquisition
|
Direct |
1,600
+50.0%
|
-
|
|
May 31
2023
|
Howard B Rosen |
BUY
Grant, award, or other acquisition
|
Direct |
2,502
+42.4%
|
-
|